# Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee

> **NCT00604539** · PHASE3 · COMPLETED · sponsor: **Bioiberica** · enrollment: 70 (estimated)

## Conditions studied

- Synovitis
- Osteoarthritis
- Joint Diseases
- Muskuloskeletal Diseases

## Interventions

- **DRUG:** Chondroitin sulphate (Condrosan)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00604539
- **Lead sponsor:** Bioiberica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2009-11
- **Final completion:** —
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2011-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00604539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00604539, "Effect of Chondroitin Sulphate on Synovial Inflammation in Patients With Osteoarthritis of the Knee". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT00604539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*